• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Medclair

2.40 SEK

+4.80 %

Less than 1K followers

MCLR

NGM Growth Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+4.80 %
-3.61 %
+2.56 %
-19.46 %
-19.46 %
+21.52 %
+101.34 %
-6.07 %
-15.96 %

Medclair is a Swedish cleantech company that develops technology for sustainable handling of nitrous oxide in healthcare, recycling and other industries using nitrous oxide. The company has an established international presence and offers solutions that aim to both reduce climate impact and improve the working environment. The headquarters are located in Stockholm.

Read more
Market cap
219.95M SEK
Turnover
383.14K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
20.8.
2026

Interim report Q2'26

5.11.
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release01.07.2026 klo 09.00

Medclair adds a new recycling customer in France

Medclair
Press release30.06.2026 klo 09.00

Folktandvården in Region Stockholm signs a framework agreement with Medclair

Medclair
Press release26.06.2026 klo 09.00

Medclair's Danish growth continues – secures order from a new region

Medclair

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release12.06.2026 klo 09.00

The first order for mobile systems in Denmark demonstrates the strength of Medclair's growth model

Medclair
Press release04.06.2026 klo 15.00

Medclair strengthens the organization with key expertise in marketing and finance

Medclair
Press release28.05.2026 klo 09.00

Medclair strengthens its position in French recycling – new deals and increased demand

Medclair
Regulatory press release07.05.2026 klo 09.00

MEDCLAIR INTERIM REPORT JANUARY–MARCH 2026

Medclair
Press release05.05.2026 klo 14.00

Medclair Lowers Barriers to Global Billion-Scale Market – New Technology Accelerates Expansion and Strengthens Market Position

Medclair
Press release05.05.2026 klo 11.10

Medclair: Q1 2026 Interim Report Presentation

Medclair
Press release29.04.2026 klo 11.40

Medclair's technology enables compliance with strict new limit values – independent French study confirms results

Medclair
Regulatory press release22.04.2026 klo 19.05

Communiqué from the Annual General Meeting of Medclair AB

Medclair
Press release22.04.2026 klo 10.30

Veolia chooses Medclair for nitrous oxide destruction in new market

Medclair
Regulatory press release19.04.2026 klo 12.20

Medclair AB – Nomination Committee’s Proposal

Medclair
Press release14.04.2026 klo 16.00

Medclair featured in French national media

Medclair
Regulatory press release01.04.2026 klo 18.31

Medclair - Annual Report 2025

Medclair
Press release31.03.2026 klo 14.45

Medclair secures dual patents for new technology in nitrous oxide management

Medclair
Regulatory press release23.03.2026 klo 12.35

Medclair receives follow-on order of SEK 5.4 million

Medclair
Regulatory press release20.03.2026 klo 13.15

Notice of Annual General Meeting in Medclair AB (publ)

Medclair
Press release14.10.2025 klo 09.00

Medclair enters new market - first installation in Belgium

Medclair
Press release09.10.2025 klo 10.15

Medclair enters partnership with Litech

Medclair